Amphastar Pharmaceuticals, Inc. — Director's Dealing 2016

Mar 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-03-26

Reporting Person: Gerst Diane G. (EVP, QA & Regulatory Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-26	Common Stock	F	614	$11.96	Disposed	32244	Direct

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.